These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activation of the phosphatidylinositol 3-kinase/Akt pathway is involved in lipocalin-2-promoted human pulmonary artery smooth muscle cell proliferation. Wang G; Ma N; Meng L; Wei Y; Gui J Mol Cell Biochem; 2015 Dec; 410(1-2):207-13. PubMed ID: 26350566 [TBL] [Abstract][Full Text] [Related]
4. IGF-1 induces iNOS expression via the p38 MAPK signal pathway in the anti-apoptotic process in pulmonary artery smooth muscle cells during PAH. Jin C; Guo J; Qiu X; Ma K; Xiang M; Zhu X; Guo J J Recept Signal Transduct Res; 2014 Aug; 34(4):325-31. PubMed ID: 24673524 [TBL] [Abstract][Full Text] [Related]
5. Niflumic Acid Attenuated Pulmonary Artery Tone and Vascular Structural Remodeling of Pulmonary Arterial Hypertension Induced by High Pulmonary Blood Flow In Vivo. Wang K; Ma J; Pang Y; Lao J; Pan X; Tang Q; Zhang F; Su D; Qin S; Shrestha AP J Cardiovasc Pharmacol; 2015 Oct; 66(4):383-91. PubMed ID: 26132368 [TBL] [Abstract][Full Text] [Related]
6. Cyanidin‑3‑O‑β‑glucoside protects against pulmonary artery hypertension induced by monocrotaline via the TGF‑β1/p38 MAPK/CREB signaling pathway. Ouyang S; Chen W; Gaofeng Z; Changcheng L; Guoping T; Minyan Z; Yang L; Min Y; Luo J Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760143 [TBL] [Abstract][Full Text] [Related]
7. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension. Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583 [TBL] [Abstract][Full Text] [Related]
8. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]
9. The reversal of pulmonary vascular remodeling through inhibition of p38 MAPK-alpha: a potential novel anti-inflammatory strategy in pulmonary hypertension. Church AC; Martin DH; Wadsworth R; Bryson G; Fisher AJ; Welsh DJ; Peacock AJ Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(4):L333-47. PubMed ID: 26024891 [TBL] [Abstract][Full Text] [Related]
10. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886 [TBL] [Abstract][Full Text] [Related]
11. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension. Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428 [TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. Tanikawa T; Okada Y; Tanikawa R; Tanaka Y J Vasc Res; 2009; 46(6):572-80. PubMed ID: 19571577 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of profilin, cofilin-2 and LIMK2 in cultured pulmonary artery smooth muscle cells and in pulmonary arteries of monocrotaline-treated rats. Dai YP; Bongalon S; Tian H; Parks SD; Mutafova-Yambolieva VN; Yamboliev IA Vascul Pharmacol; 2006 May; 44(5):275-82. PubMed ID: 16524786 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism by which hydrogen sulfide regulates pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats]. Li XH; Du JB; Bu DF; Tang CS Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):941-5. PubMed ID: 17254467 [TBL] [Abstract][Full Text] [Related]
15. Xanthine oxidase-derived extracellular superoxide anions stimulate activator protein 1 activity and hypertrophy in human vascular smooth muscle via c-Jun N-terminal kinase and p38 mitogen-activated protein kinases. Matesanz N; Lafuente N; Azcutia V; Martín D; Cuadrado A; Nevado J; Rodríguez-Mañas L; Sánchez-Ferrer CF; Peiró C J Hypertens; 2007 Mar; 25(3):609-18. PubMed ID: 17278978 [TBL] [Abstract][Full Text] [Related]
16. Endothelin A receptor blockade improves regression of flow-induced pulmonary vasculopathy in piglets. Mercier O; Sage E; Izziki M; Humbert M; Dartevelle P; Eddahibi S; Fadel E J Thorac Cardiovasc Surg; 2010 Sep; 140(3):677-83. PubMed ID: 20723731 [TBL] [Abstract][Full Text] [Related]
17. The serum- and glucocorticoid-inducible kinase Sgk-1 is involved in pulmonary vascular remodeling: role in redox-sensitive regulation of tissue factor by thrombin. BelAiba RS; Djordjevic T; Bonello S; Artunc F; Lang F; Hess J; Görlach A Circ Res; 2006 Mar; 98(6):828-36. PubMed ID: 16484615 [TBL] [Abstract][Full Text] [Related]
18. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling. Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492 [TBL] [Abstract][Full Text] [Related]
20. Responses of vascular smooth muscle cells to estrogen are dependent on balance between ERK and p38 MAPK pathway activities. Cheng B; Song J; Zou Y; Wang Q; Lei Y; Zhu C; Hu C Int J Cardiol; 2009 May; 134(3):356-65. PubMed ID: 18584900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]